X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3738) 3738
Publication (651) 651
Book Review (29) 29
Dissertation (13) 13
Book Chapter (11) 11
Conference Proceeding (3) 3
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2891) 2891
index medicus (2816) 2816
female (1485) 1485
oncology (1446) 1446
immunotherapy (1311) 1311
b7-h1 antigen - metabolism (1249) 1249
male (1189) 1189
animals (1126) 1126
cancer (1104) 1104
pd-l1 (1069) 1069
middle aged (960) 960
immunology (891) 891
aged (834) 834
mice (784) 784
b7-h1 antigen - immunology (766) 766
adult (758) 758
expression (752) 752
b7-h1 (738) 738
b7-h1 antigen - genetics (722) 722
apoptosis (711) 711
pd-1 (709) 709
b7-h1 antigen - antagonists & inhibitors (693) 693
prognosis (689) 689
lymphocytes (654) 654
immunohistochemistry (648) 648
tumors (588) 588
ligands (570) 570
t cells (531) 531
pd-l1 protein (524) 524
blockade (508) 508
b7-h1 antigen (494) 494
programmed cell death 1 receptor - antagonists & inhibitors (482) 482
nivolumab (476) 476
programmed cell death 1 receptor - metabolism (448) 448
article (443) 443
cell line, tumor (441) 441
aged, 80 and over (437) 437
t-cells (428) 428
melanoma (420) 420
programmed cell death 1 receptor - immunology (406) 406
activation (392) 392
gene expression (389) 389
chemotherapy (383) 383
dendritic cells (380) 380
safety (380) 380
antibodies, monoclonal - therapeutic use (377) 377
care and treatment (375) 375
survival (372) 372
mice, inbred c57bl (353) 353
t-lymphocytes - immunology (348) 348
immunotherapy - methods (345) 345
cell biology (344) 344
research (341) 341
lymphocytes t (338) 338
pd-1 protein (335) 335
metastasis (330) 330
cd8-positive t-lymphocytes - immunology (324) 324
analysis (321) 321
lung cancer (320) 320
immune checkpoint (319) 319
b7 family (316) 316
carcinoma (313) 313
health aspects (311) 311
pathology (308) 308
pembrolizumab (298) 298
flow cytometry (296) 296
pd-l1 expression (294) 294
antineoplastic agents - therapeutic use (291) 291
patients (278) 278
lung neoplasms - pathology (277) 277
b7-h1 antigen - biosynthesis (269) 269
cell death (266) 266
abridged index medicus (263) 263
medical prognosis (262) 262
up-regulation (260) 260
antibody (259) 259
biomarkers, tumor - metabolism (257) 257
signal transduction (256) 256
tumor-infiltrating lymphocytes (255) 255
gene expression regulation, neoplastic (250) 250
treatment outcome (250) 250
biomarkers (247) 247
neoplasms - immunology (247) 247
programmed cell death 1 receptor (246) 246
immunity (243) 243
antigens (242) 242
medicine, research & experimental (241) 241
lymphocytes, tumor-infiltrating - immunology (240) 240
neoplasm staging (240) 240
therapy (237) 237
immune system (236) 236
mutation (235) 235
immune response (231) 231
cancer therapies (227) 227
tumor microenvironment (226) 226
b7-h1 antigen - analysis (224) 224
genetic aspects (219) 219
responses (219) 219
b7-h1 expression (218) 218
pathway (218) 218
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3615) 3615
Chinese (72) 72
French (23) 23
Japanese (14) 14
German (9) 9
Polish (4) 4
Czech (2) 2
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical pathology, ISSN 0021-9746, 03/2018, Volume 71, Issue 3, pp. 189 - 194
Programmed death ligand 1 (PD-L1) is the principal ligand of programmed death 1 (PD-1), a coinhibitory receptor that can be constitutively expressed or induced... 
oncogenes | immunology | cancer | T-CELL PROLIFERATION | ACTIVATION | MELANOMA | PEMBROLIZUMAB | B7-H1 EXPRESSION | OVARIAN-CANCER | PATHOLOGY | CARCINOMA | PHOSPHOLIPASE C-GAMMA | LIGAND 1 EXPRESSION | LYMPHOCYTES | Antigens | Amino acids | Cytotoxicity | Proteins | Signal transduction | Lymphocytes | Pancreatic cancer | Medical prognosis | Immunotherapy | Ligands | Physiology | Lymphomas | Tumors
Journal Article
Modern Pathology, ISSN 0893-3952, 10/2016, Volume 29, Issue 10, pp. 1165 - 1172
Immunohistochemistry of the PD-L1 protein may be predictive for anti-PD-1 and anti-PD-L1 immunotherapy in pulmonary adenocarcinoma and in clinically unselected... 
SURVIVAL | LUNG-CANCER | MULTICENTER | PEMBROLIZUMAB | GASTRIC-CANCER | LONG-TERM SAFETY | DEATH-LIGAND 1 | ANTIBODY | PATHOLOGY | NIVOLUMAB | DOCETAXEL | Adenocarcinoma | Carcinoma, Squamous Cell | Immunohistochemistry - methods | Biomarkers, Tumor - analysis | Humans | B7-H1 Antigen - analysis | Lung Neoplasms | Observer Variation
Journal Article
Journal Article